Canine parvovirus induces G1/S cell cycle arrest that involves EGFR Tyr1086 phosphorylation

References

• Singh P, Destito G, Schneemann A, et al. Canine parvovirus-like particles, a novel nanomaterial for tumor targeting. J Nanobiotechnology. 2006;4:2.
   PubMedGoogle Scholar
• Gomme PT, McCann KB, Bertolini J. Transferrin: structure, function and potential therapeutic actions. Drug Discov Today. 2005;10(4):267–273.
   PubMed Web of Science ®Google Scholar
• Kiprianova I, Thomas N, Ayache A, et al. Regression of glioma in rat models by intranasal application of parvovirus h-1. Clin Cancer Res. 2011;17(16):5333–5342.
   PubMed Web of Science ®Google Scholar
• Inoue T, Cavanaugh PG, Steck PA, et al. Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials. J Cell Physiol. 1993;156(1):212–217.
   PubMed Web of Science ®Google Scholar
• Becker A, Riefke B, Ebert B, et al. Macromolecular contrast agents for optical imaging of tumors: comparison of indotricarbocyanine-labeled human serum albumin and transferrin. Photochem Photobiol. 2000;72(2):234–241.
   PubMed Web of Science ®Google Scholar
• Sato Y, Yamauchi N, Takahashi M, et al. In vivo gene delivery to tumor cells by transferrin-streptavidin-DNA conjugate. Faseb J. 2000;14(13):2108–2118. .
   PubMed Web of Science ®Google Scholar
• Ryschich E, Huszty G, Knaebel HP, et al. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur J Cancer. 2004;40(9):1418–1422.
   PubMed Web of Science ®Google Scholar
• Angelova AL, Witzens-Harig M, Galabov AS, et al. The oncolytic virotherapy era in cancer management: prospects of applying H-1 parvovirus to treat blood and solid cancers. Front Oncol. 2017;7:93.
   PubMed Web of Science ®Google Scholar
• Koks CA, De Vleeschouwer S, Graf N, et al. Immune suppression during oncolytic virotherapy for high-grade glioma; yes or no? J Cancer. 2015;6(3):203–217.
   PubMed Web of Science ®Google Scholar
• Op De Beeck A, Sobczak-Thepot J, Sirma H, et al. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1). J Virol. 2001;75(22):11071–11078.
   PubMed Web of Science ®Google Scholar
• Op De Beeck A, Anouja F, Mousset S, et al. The nonstructural proteins of the autonomous parvovirus minute virus of mice interfere with the cell cycle, inducing accumulation in G2. Cell Growth Differ. 1995;6(7):781–787.
   PubMedGoogle Scholar
• Adeyemi RO, Pintel DJ. Replication of minute virus of mice in murine cells is facilitated by virally induced depletion of p21. J Virol. 2012;86(15):8328–8332.
   PubMed Web of Science ®Google Scholar
• Hristov G, Kramer M, Li J, et al. Through its nonstructural protein NS1, parvovirus H-1 induces apoptosis via accumulation of reactive oxygen species. J Virol. 2010;84(12):5909–5922.
   PubMed Web of Science ®Google Scholar
• Chen AY, Qiu J. Parvovirus infection-induced cell death and cell cycle arrest. Future Virol. 2010;5(6):731–743.
   PubMed Web of Science ®Google Scholar
• Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999;39::295–312.
   PubMed Web of Science ®Google Scholar
• Branzei D, Foiani M. Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol. 2008;9(4):297–308.
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang J, Song F, et al. EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1. Cancer Lett. 2016;381(2):331–340. .
   PubMed Web of Science ®Google Scholar
• Huang D, Jokela M, Tuusa J, et al. E2F mediates induction of the Sp1-controlled promoter of the human DNA polymerase epsilon B-subunit gene POLE2. Nucleic Acids Res. 2001;29(13):2810–2821.
   PubMed Web of Science ®Google Scholar
• Kucherlapati MH. Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation. Oncotarget. 2019;10(65):6913–6933.
   PubMedGoogle Scholar
• Lipskaia L, Lompre AM. Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation. Biol Cell. 2004;96(1):55–68.
   PubMed Web of Science ®Google Scholar
• Munaron L, Antoniotti S, Lovisolo D. Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med. 2004;8(2):161–168.
   PubMed Web of Science ®Google Scholar
• Takuwa N, Iwamoto A, Kumada M, et al. Role of Ca2+ influx in bombesin-induced mitogenesis in Swiss 3T3 fibroblasts. J Biol Chem. 1991;266(3):1403–1409.
   PubMed Web of Science ®Google Scholar
• Leger K, Hopp AK, Fey M, et al. ARTD1 regulates cyclin E expression and consequently cell-cycle re-entry and G1/S progression in T24 bladder carcinoma cells. Cell Cycle. 2016;15(15):2042–2052.
   PubMed Web of Science ®Google Scholar
• Liu F, Lee WH. CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression. Mol Cell Biol. 2006;26(8):3124–3134.
   PubMed Web of Science ®Google Scholar
• Kim Y, Apetri M, Luo B, et al. Differential Effects of Tyrosine Kinase Inhibitors on Normal and Oncogenic EGFR Signaling and Downstream Effectors. Mol Cancer Res. 2015;13(4):765–774.
   PubMed Web of Science ®Google Scholar
• Choi HI, Kim DH, Park JS, et al. Peroxiredoxin V (PrdxV) negatively regulates EGFR/Stat3-mediated fibrogenesis via a Cys48-dependent interaction between PrdxV and Stat3. Sci Rep. 2019;9(1):8751.
   PubMedGoogle Scholar
• Dai X, Wang C, Lam JCW, et al. Accumulation of quaternary ammonium compounds as emerging contaminants in sediments collected from the Pearl River Estuary, China and Tokyo Bay, Japan. Mar Pollut Bull. 2018;136::276–281.
   PubMed Web of Science ®Google Scholar
• Eskens FA, Mom CH, Planting AS, et al. A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours. Br J Cancer. 2008;98(1):80–85. .
   PubMed Web of Science ®Google Scholar
• Morandell S, Stasyk T, Skvortsov S, et al. Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network. Proteomics. 2008;8(21):4383–4401.
   PubMed Web of Science ®Google Scholar
• Sturla LM, Amorino G, Alexander MS, et al. Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2. J Biol Chem. 2005;280(15):14597–14604.
   PubMed Web of Science ®Google Scholar
• Weng MS, Chang JH, Hung WY, et al. The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance. J Exp Clin Cancer Res. 2018;37(1):61.
   PubMedGoogle Scholar
• Gamou S, Shimizu N. Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor. FEBS Lett. 1995;357(2):161–164.
   PubMed Web of Science ®Google Scholar